NCT07723209|RecruitingDMC
Radiation After No Axillary Nodal Sampling
RADIANS
RADIation After no Axillary Nodal Sampling (RADIANS)
Loading search results
RADIANS
RADIation After no Axillary Nodal Sampling (RADIANS)
Sponsor study identifier
interventional
105
1 country
1
Study Start
July 9, 2026
Actual (reported)Primary Completion
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Study Completion
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
This is a single arm, pilot, prospective study to evaluate the safety of partial breast irradiation in women who undergo breast conserving surgery without sentinel lymph node biopsy (SLNB) or axillary lymph node dissection (ALND). Baseline demographic and clinical information will be collected. All patients will complete the Breast Cancer Treatment Outcome Scale (BCTOS-13) questionnaire and the Functional Assessment of Chronic Illness Therapy-Comprehensive Score for financial Toxicity at baseline and at 2 years. All patients are required to have an axillary ultrasound prior to radiation start if this was not obtained pre-operatively.
Registry-reported information. Elapsed time and enrollment totals alone do not measure study progress or recruitment pace.
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Click on a node to explore related trials.
Some registry-reported names shown below are not yet linked in this graph.
Dates and qualifiers reported by the registry. Estimated dates do not confirm that a milestone has occurred.
July 9, 2026
Actual (reported)July 20, 2026
Actual (reported)July 23, 2026
Actual (reported)July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Rate of Axillary Recurrence
Proportion of patients in whom the return of breast cancer in the lymph nodes of the armpit is observed.
Up to Year 5-post-radiation
Rate of Local Recurrence
Up to Year 5-post-radiation
Rate of Distant Recurrence
Up to Year 5-post-radiation
Breast-Cancer Specific Survival
Up to Year 5-post-radiation
Overall Survival
Up to Year 5-post-radiation
Rate of Endocrine Therapy Initiation
Up to Year 5-post-radiation
Patients in whom a sentinel lymph node biopsy is omitted will receive Partial Breast Irradiation (PBI).
Delivered using 3D or 3D/IMRT or IMRT techniques following breast-conserving surgery.
Registry-reported names are shown in full. Names without a link have not yet been matched to a Syfrah profile.
NYU Langone Health
New York, New York, 10016, United States
Naamit Gerber, MD
NYU Langone Health
First Submitted
July 20, 2026
First Posted
July 23, 2026
Study Start
July 9, 2026
Actual (reported)Primary Completion
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
A Couples Approach to Enhance Breast Cancer Survivorship
Contact the study team to confirm eligibility.
Study Completion
July 31, 2034
EstimatedPlanned date reported by the registry; this milestone is not confirmed as achieved.
Last Updated
July 23, 2026
Record last verified: 2026-07
No plans to share de-identified IPD with other researchers at this time.
Download the complete ClinicalTrials.gov record imported by Syfrah, including fields not shown in this page. The registry may contain a newer revision.
Source: ClinicalTrials.gov.
JSON downloads include source attribution and retrieval details alongside the unchanged original record or the separately normalized values.
Source retrieved: